Genotoxic markers in patients with diabetes mellitus (Literature review)

This paper considers studies aimed at identifying markers of genotoxicity (chromosomal aberrations, micronuclei, and DNA damage assessed by the comet assay) in patients with both gestational diabetes mellitus (GDM) type 1 2 (T1DM T2DM, respectively), as well possible changes levels these genotoxic under influence medicines nutritions. Patients T2DM are characterized an increased level markers. The results T1DM GDM contradictory, however, they indicate presence load rather than its absence. diabetic may be reduced physical exercises, diet, and/or hypoglycemic drugs. Metformin, Afobazole Noopept recommended for experimental clinical drug candidates that reduce biomarkers patients.